Primo N. Lara, MD
University of California, Davis
13
4
11
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+20 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Kenneth J. Pienta, MD, FACP
University of Michigan Rogel Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Maha Hadi A. Hussain, MD
University of Michigan Rogel Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Naomi S. Balzer-Haas, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Darren Hillegonds, PhD
Lawrence Livermore National Laboratory at University of California
Shared therapeutic areas:
Worked with same sponsors:
David I. Quinn, MD
University of Southern California
Shared therapeutic areas:
Worked with same sponsors:
David R. Gandara, MD
University of California, Davis
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Ronald B. Natale, MD
Cedars-Sinai Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Gregory P. Swanson, MD
Deaconess Medical Center, Spokane, Washington
Shared therapeutic areas:
Worked with same sponsors:
Arif Hussain, MD
University of Maryland Greenebaum Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
R115777 in Treating Patients With Advanced Solid Tumors
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sorafenib in Treating Patients With Advanced Malignant Solid Tumors
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis
All 13 trials loaded